期刊文献+

紫杉醇和顺铂联合调强放疗治疗宫颈癌的临床疗效 被引量:12

Clinical effect of paclitaxel and cisplatin combined with intensity modulated radiotherapy on treatment of cervical carcinoma
下载PDF
导出
摘要 目的探讨紫杉醇和顺铂联合调强放疗治疗局部晚期宫颈癌的临床疗效。方法收集成都市第五人民医院、四川省肿瘤医院于2010至2015年收治的局部晚期初治年轻宫颈癌患者121例为研究对象,将其分为对照组和观察组。观察组患者60例,以顺铂为基础的同步放化疗(CCRT)后行紫杉醇和顺铂联合巩固性化疗2个周期;对照组患者61例,仅行顺铂为基础的同步放化疗。比较两组患者的近期治疗有效率、副反应发生率,及1年、2年生存率。结果在放疗结束后3个月,宫颈癌患者治疗的总有效率观察组和对照组分别为98.33%和93.44%,两组差异无统计学意义(P>0.05);副反应比较两组差异无统计学意义(P>0.05);1年生存率比较两组差异无统计学意义(P>0.05),2年生存率比较两组差异有统计学意义(χ~2=3.97,P=0.04<0.05)。结论同步放化疗后进行紫杉醇和顺铂联合巩固性化疗能够提高局部晚期宫颈癌患者的远期生存率。 Objective To evaluate the clinical efficacy of cisplatin and paclitaxel combined with intensity modulated radiotherapy(IMRT)on the treatment of locally advanced cervical carcinoma.Methods Totally 121 patients with locally advanced cervical carcinoma,who were admitted in Chengdu Fifth People's Hospital and Sichuan Cancer Hospital from 2010 to 2015,were divided into control group and observation group.Sixty patients in the observation group accepted cisplatin-based concomitant chemoradiotherapy(CCRT)followed by paclitaxel and cisplatin to consolidate chemotherapy for 2 cycles,and 61 patients in the control group were treated with CCRT.The recent treatment efficiency,side effects and 1 year,2-year survival rate were compared.Results Three months after radiotherapy,the total effective rates of the observation group and the control group were98.33% and 93.44%,respectively,and the difference was not statistically significant(P〉0.05).The side effects between two groups was not statistically significant(P〉0.05).There was no significant difference in the 1-year survival rate between two groups(P〉0.05),and the 2-year survival rate was significantly different(χ^2=3.97,P〈0.05).Conclusion After CCRT,paclitaxel combined with cisplatin for consolidating chemotherapy can improve the long-term survival of patients with locally advanced cervical cancer.
作者 李芷茹 曾守群 李超 罗莉 黄叶才 LI Zhi-ru;ZENG Shou-qun;LI Chao;LUO Li;HUANG Ye-cai(Department of Oncoiogy,Chengdu Fifth People's Hospital,Sichuan Chengdu 611130,China;Department of Obstetrics and Gynecology,Chengdu Fifth People's Hospital,Sichuan Chengdu 610030,China;Department of Radiation Oncology,Sichuan Cancer Hospital,Sichuan Chengdu 610041,China)
出处 《中国妇幼健康研究》 2018年第7期929-932,共4页 Chinese Journal of Woman and Child Health Research
关键词 紫杉醇 顺铂 调强放疗 局部晚期宫颈癌 同步放化疗 paclitaxel cisplatin intensity modulated radiotherapy (IMRT) locally advanced cervical carcinoma concomitant chemoradiotherapy (CCRT)
  • 相关文献

参考文献3

二级参考文献31

  • 1管忠震,徐瑞华.奈达铂临床研究进展[J].中国肿瘤临床,2004,31(13):774-780. 被引量:176
  • 2Whitney CW, Sause W, Bundy BN, et al. A randomized comparison of fluorouraeil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages Ⅱ B-ⅣA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Ontology Group and Southwest Oncology Group stndy [ J ] . J Clin Oncol, 1999, 17 [ 5 ] : 1339-1348.
  • 3Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: a randomized Radiation Therapy Oncology Group clinical trial [ J ] . N Engl J Med, 1999, 340 [ 15 ] : 1137-1143.
  • 4Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based chemoradiation improves progression free and overall survival in advanced cervical cancer: results of a randomized Gynecologic Oncology Group study [J].N Engl J Med, 1999,340 [15] :1144-1153.
  • 5Peters WA 3rd, Liu PY, Barrett RJ, et al. Cisplatin and 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunetive in high-risk early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a phase Ⅲ intergroup study [J]. J Clin Oncol, 2000, 18 [ 8 ] : 1606-1613.
  • 6Keys HM, Bundy BM, Stehman FB, et al. A comparison of weekly c, isplatin during radiation therapy versus irradiation alone each followed by adjuvant hysterectomy in bulky stage Ⅰ B cervical carcinoma: a randomized trial of the Gynecologic Oncology Group [ J ] . N Engl J ned, 1999, 340 [ 15 ] : 1154-1161.
  • 7Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine eervix: a systemic review and metaanalysis [ J ] . Lancet, 2001, 358 [ 9284 ] : 781-786.
  • 8Ikushima H, Osaki K, Furutani S, et al. Chemoradiation therapy for cervical cancer: toxicity of concurrent weekly cisplatin [ J ]. Radiat Med, 2006, 24 [ 2 ] :115-121.
  • 9Serkies K, Jassem J. Concurrent weekly cisplatin and radiotherapy in rontine management of cervical cancer: a report on patient compliance and acute toxicity. Int J Radiat Oncol Biol Phys, 2004. 60 [ 3 ] :814-821.
  • 10McGuire WP, Blessing JA, Moore D, et al. Paclitaxel has moderate activity in squamous cervix cancer: a Gynecologic Oncology Group Study. J Clin Oncol, 1996, 14[3]:792-795.

共引文献39

同被引文献124

引证文献12

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部